Opportunistic Salpingectomy: New Cancer Prevention Strategy for Ovarian Cancer

With limited effective treatments for ovarian cancer, should a proactive approach involve encouraging opportunistic salpingectomy, as proposed by the European Society of Gynaecological Oncology (ESGO) in an article, Opportunistic Salpingectomy for prevention of tubo ovarian carcinoma, published online February 2, 2026 (Piek JM et al., JAMA, 2026)?

A Shift in Understanding Ovarian Cancer

This proposal stems from recent confirmation of pathophysiological data. The fallopian tube is believed to be the site of origin for a significant portion of high-grade serous ovarian cancers, the most common form of epithelial ovarian cancer, also called tubo-ovarian carcinoma. This change in understanding has led to the development and adoption of opportunistic salpingectomy – the removal of the fallopian tubes during other surgical procedures, as a preventative measure.

ESGO’s Consensus and Definition

Before issuing this recommendation, ESGO convened a multidisciplinary panel of experts in surgery, oncology, pathology, and public health to reach a consensus, based on a systematic review of the literature and a multi-round DELPHI process.

ESGO defines opportunistic salpingectomy as the complete bilateral removal of the fallopian tubes in women at standard population risk, performed during benign pelvic surgery (hysterectomy, definitive sterilization, endometriosis surgery, etc.).

Extensive Review of Existing Research

A total of 230 studies were initially selected for review by a methodologist. After review by working groups, 129 articles were retained for statement formulation, with 21 of these studies and their respective levels of evidence analysed.

Did You Know? More than 3 million women were included in observational studies examining the impact of salpingectomy.

Potential Benefits and Considerations

Observational studies indicate a 20 to 65% reduction in the risk of tubo-ovarian cancer (CTO) in women who underwent bilateral, non-prophylactic salpingectomy, with no demonstrated detrimental effect on ovarian function measured by AMH or ovarian stimulation response. Additional surgical complications are rare, and the incremental cost is low, particularly when coupled with a planned gynecological procedure.

Opportunistic salpingectomy should be considered for all women of reproductive age at standard risk when a pelvic surgical indication exists. For premenopausal women, a clear discussion regarding the absence of immediate contraceptive effect and the maintenance of ovarian function is essential.

Excision should be complete, including the intra-uterine fimbrial portion. In cases of hysterectomy, ovarian conservation is recommended if age and clinical context permit.

Specific Cases

For women at high risk (BRCA1/2, Lynch syndrome), opportunistic salpingectomy is not an alternative to recommended prophylactic salpingo-oophorectomy, but may be a transitional step (“two-step approach”) for younger women wishing to delay surgical menopause.

All removed tubes should undergo histological examination according to the SEE-FIM protocol to identify potential STIC (serous tubal intraepithelial carcinoma) lesions, which would necessitate a specific oncological assessment.

Expert Insight: The ESGO’s recommendation represents a shift towards preventative measures for ovarian cancer, acknowledging the limitations of current detection methods and the need for new prevention options.

Potential Impact and Future Research

European modeling estimates that widespread adoption of opportunistic salpingectomy during hysterectomies or sterilizations could prevent more than 2,000 deaths per year in the long term. This strategy is considered cost-effective and safe, especially in healthcare systems with broad access to planned gynecological surgery.

The authors acknowledge the lack of randomized data, although prospective trials (NOTABLE, TUBA, HOPPSA) are underway. Long-term monitoring of ovarian function and patient satisfaction will need to be confirmed by extended cohort studies.

Considerations for Younger Women

Regret related to fertility after opportunistic salpingectomy has not been specifically studied. However, for women seeking sterilization, salpingectomy should be the preferred method over tubal ligation, given its potential to reduce the risk of tubo-ovarian cancer. There are currently no specific recommendations for young, premenopausal women, and opportunistic salpingectomy should not be performed in emergency surgical settings or when future fertility desires are unknown.

The ESGO consensus concludes that opportunistic salpingectomy represents a realistic, simple, and effective preventative measure against tubo-ovarian carcinoma in the general population. Its integration into routine gynecological practise, with adherence to information rules and surgical quality, could mark a major advance comparable to HPV vaccination in cervical cancer pathology.

Frequently Asked Questions

What is opportunistic salpingectomy?

Opportunistic salpingectomy is the complete bilateral removal of the fallopian tubes in women at standard population risk, performed during benign pelvic surgery (hysterectomy, sterilization, endometriosis surgery, etc.).

What risk reduction has been observed with this procedure?

Observational studies indicate a 20 to 65% reduction in the risk of tubo-ovarian cancer in women who underwent bilateral, non-prophylactic salpingectomy.

Is this procedure appropriate for all women?

Opportunistic salpingectomy should be considered for all women of reproductive age at standard risk when a pelvic surgical indication exists, but is not recommended in emergency situations or when future fertility is desired.

As research continues and more data becomes available, how might preventative strategies for ovarian cancer evolve in the coming years?